Cooper Companies' stock underperforms, drops 12.8% in past three months, tumbles 14.6% post Q2 results

From Yahoo Finance: 2025-06-19 11:20:00

The Cooper Companies, Inc. is a California-based global medical device company with a market cap of $14 billion, focusing on contact lenses, eye care products, and women’s health solutions. Despite recent declines in stock value, the company posted strong Q2 results, exceeding revenue and EPS expectations. Analysts maintain a “Moderate Buy” rating.

Shares of COO have dropped significantly from their 52-week high, with a 12.8% decline in the past three months. The stock has underperformed its competitor, Align Technology, Inc., over the past year. Despite fluctuations, COO has been trading below its moving averages since late 2025.

COO’s long-term performance shows a 24.1% YTD drop, notably worse than its competitor. Despite beating Q2 revenue and EPS estimates, the stock tumbled 14.6% due to a lowered full-year growth outlook. Analysts remain cautiously optimistic about COO’s future prospects, with a consensus rating of “Moderate Buy.”

Read more: How is Cooper Companies’ Stock Performance Compared to Other Medical Instruments & Supplies Stocks?